You are here

Journal of International Medical Research

Journal of International Medical Research


eISSN: 14732300 | ISSN: 03000605 | Current volume: 52 | Current issue: 9 Frequency: Monthly

The Journal of International Medical Research(JIMR) is an SCIE-ranked peer-reviewed, open access journal that publishes original clinical and preclinical research, systematic and narrative reviews, meta-analyses, and case reports across all areas of medicine. Please see the aims and scope tab for further information.

Journal Highlights

  • Launched in 1972.
  • Global visibility due to international audience of multidisciplinary researchers.
  • Official Impact Factor is 1.6 (SCIE), CiteScore is 2.6.
  • Indexed In: Clarivate Analytics: Science Citation Index Expanded (SCIE), PubMed Central (PMC), PubMed: MEDLINE, Scopus, EMBASE, Index Medicus, and the Directory of Open Access Journals (DOAJ).
  • Gold open access journal: all articles are made freely available online on our website and on PubMedCentral.
  • Rigorous peer review and decision making with high standards of publication.
  • Global visibility due to international audience of multidisciplinary researchers.
  • Publication is subject to payment of an article processing charge (APC) that includes high-quality editing of all accepted papers.
  • Reviewers get credit for their work via journal partnership with Clarivate Reviewer Recognition (formerly Publons).

Diversity, Equity and Inclusion Statement

The Journal of International Medical Research promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the medical research community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.

Submission Information

Submit your manuscript today at http://mc.manuscriptcentral.com/jimr.

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.

Page Charge Information

Publication in the journal is subject to payment of a page charge, which serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license. The current rate is £325 GBP per printed page. The page charge fee is based on the page count estimate made after submission and is payable upon provisional acceptance for scientific and language editing before publication. The charge includes a high-quality editing step for all accepted papers. The page charge is payable only when a manuscript is accepted after peer review, before it is published. The page charge is subject to taxes where applicable. Please see further details here.

Contact

Please direct any queries to JIMR.admin@sagepub.com.

Criteria for Publication

Our goal is to publish research done well. This means we look for research that adds to the academic record, either as novel or corroborative evidence, and adheres to ethical standards, uses robust methodologies that are transparent and reproducible, and uses appropriate statistical analyses to ensure clear, credible, and trustworthy results. The Journal of International Medical Research evaluates manuscripts based on how the research was conducted and reported.

  • All manuscripts:
  • must comply with the Helsinki Declaration of 1975 and EQUATOR Network reporting guidelines (e.g. CONSORT for randomized, controlled trials, PRISMA for systematic reviews/meta-analyses, STROBE for most observational studies, ARRIVE for animal studies and CARE for case reports).
  • are subject to single-blind peer review (comments from at least two external peer reviewers).
  • receive high-quality scientific and language editing before publication.
  • The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable.

Scope

The Editors are looking for medical research that adds to the existing literature either as novel or corroborative evidence. We will consider replication studies and negative/null results studies.

We welcome manuscripts across all the main fields, branches, specialties (and subspecialties) and therapeutic areas of medicine. This includes: allergy and immunology, anaesthesia and analgesia, bioinformatics, cardiology, cardiovascular system, clinical epidemiology, clinical pharmacology, critical care, dentistry, dermatology, diabetes and endocrinology, emergency medicine, gastroenterology, geriatrics, haematology, hepatology, immunology, infectious disease, men’s health, musculoskeletal disease, nephrology, neurology, obstetrics and gynaecology, oncology (all solid tumours), ophthalmology, oral and dental health, orthopaedics, otorhinolaryngology, paediatrics and neonatology, pharmacology, psychiatry, regenerative medicine, respiratory disease, rheumatology, sexual health, sports medicine, surgery (all areas), therapeutics, urology, women’s health.

We publish original clinical research (randomised controlled trials, observational studies) and preclinical research (in vitro studies, animal studies, in silico studies), systematic reviews and meta-analyses, narrative reviews, and case reports/series.

We do not publish the following research:

  • Public health studies, social/nursing care studies, epidemiology studies, health economics and outcomes research
  • Alternative and complementary medicine
  • Bioinformatics without clinical, in vitro, or in vivo validation
  • in vitro cell lines studies without in vivo/clinical validation; in silico studies without supporting evidence of their downstream effects in vivo or in vitro
  • Simple database studies, simple bibliographic studies, common cases
  • Studies with limited international appeal that are more suited for a local or niche journal
  • Life science and engineering studies: these may be suitable for our sister publication, Science Progress.

You can submit a manuscript at any time. Please also consider our lists of Special Topics and Special Collections.

 

Editor
Matthew Thorne, PhD SAGE Publications Ltd, UK
Michaela Christodoulaki, PhD SAGE Publications Ltd, UK
Managing Editors
Gordon Mallarkey, PhD SAGE Publications Ltd, UK
Sara Morris, MSc SAGE Publications Ltd, UK
Associate Editor
Lingling Tian SAGE Publishing, Shanghai, China
Editorial Board
Albiruni Razak Princess Margaret Cancer Centre, Toronto, Canada
Kathryn Abel University of Manchester, Manchester, UK
Fateen Ata Hamad Medical Corporation, Doha, Qatar
Suleyman Aydin Firat University, Turkey
Deepak Babu, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, USA
Melissa Badowski University of Illinois at Chicago, Chicago, IL, USA
Matteo Bassetti University of Udine and Azienda Sanitaria Universitaria Integrata, Udine, Italy
Nuray Bayar Muluk Kirikkale University, Turkey
Angel Becerra-Bolaños Doctor Negrín University Hospital of Gran Canaria, Canary Islands, Spain
Alexander Berezin Zaporozhye State Medical University, Ukraine
Massimo Bonacchi University of Florence, Florence, Italy
Yong-Jun Cha Daejeon University, Republic of Korea
Madhuradhar Chedongi University of Iowa, Iowa City, IA, USA
H Cheng Xiamen University, Xiamen, Fujian, China
Sheue-Yann Cheng National Cancer Institute, Bethesda, USA
Zeyi Cheng Sichuan University, Chengdu, China
Kumaraswamy Chitrala University of Houston, Texas, USA
William Cho !Queen Elizabeth Hospital, Hong Kong
Simon Chu Hudson Institute of Medical Research, Clayton, VIC, Australia
Andrea Ciorba University Hospital of Ferrara, Italy
Indranil Dasgupta University Hospitals Birmingham NHS Foundation Trust, Heartlands Hospital, Birmingham, UK
Jorge A. Garcia Case Western Reserve University, Cleveland, OH, USA
Matteo Ghilli University Hospital of Pisa, Pisa, Italy
Syed Adeel Hassan University of Kentucky, Kentucky, USA
Giovanni Iolascon University of Campania "L.Vanvitelli", Italy
Miljana z. Jovandaric University Clinical Center of Serbia, Serbia
Ali Fahim Khan University of Oklahoma Health Sciences Center, Oklahoma, USA
Young-Kug Kim Asan Medical Center, University of Ulsan College of Medicine, Republic of Korea
Constantine E. Kosmas National and Kapodistrian University of Athens, University General Hospital “ATTIKON”, Athens, Greece
Ichiro Kurokawa Meiwa Hospital, Nishinomiya, Hyogo, Japan
Anna Lavezzi University of Milan, Italy
Nicolas Lecomte David M. Rubenstein CPCR, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Gun Woo Lee Yeungnam University College of Medicine, Gyeongsan, Republic of Korea
Hyun Jung Lee Chung-Ang University, Seoul, Republic of Korea
Jimmy K. Limdi Northern Care Alliance NHS Foundation Trust & University of Manchester, Manchester, UK
Jian Liu Beijing Tian Tan Hospital, Beijing, China
Hui Luo The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Zhaojie Lyu Peking University Shenzhen Hospital, Shenzhen, China
Zhengtao Lyu Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Monia Marchetti, MD, PhD Azienda Ospedaliera Universitaria SS Antonio e Biagio e Cesare Arrigo, Italy
Elizabeth J. Maynes, MD Uniformed Services University of the Health Sciences, USA
Patrick Meloy Emory University School of Medicine, Atlanta, GA, USA
Francesco Menzella AULSS2 Marca Trevigiana, Italy
Antimo Moretti University of Campania ‘Luigi Vanvitelli’, Caserta, Italy
Francesco Nappi Centre Cardiologique du Nord, Saint-Denis, France
Dionysis Nikolopoulos Karolinska Institutet, Sweden
Uwe Nixdorff European Prevention Center, Germany
Gaetano Nucifora University of Manchester/Manchester University NHS Foundation Trust, UK
Daniele Orsucci Unit of Neurology, San Luca Hospital of Lucca, Lucca, Italy
Georgios D Panos Nottingham University Hospitals NHS Trust, Nottingham, UK
Federica Piani University of Bologna, Bologna, Italy
Hui-Qi Qu Children’s Hospital of Philadelphia, Pennsylvania, USA
Janet Rimmer St Vincent's Hospital, Sydney, NSW, Australia
Jose Juan Pereyra Rodriguez Virgen del Rocío University Hospital/ University of Sevilla, Spain
Luca Roncati University Hospital of Modena, University of Modena and Reggio Emilia, Italy
Nahum Rosenberg National Insurance Institute, Jerusalem, Israel
Alessio Rungatscher University of Verona, Verona, Italy
Irfan Shafi Wayne State University, USA
Nada Shaker Ohio State University, Wexner Medical Center, Columbus, Ohio, USA
Suresh Kumar Sharma Panjab University, Chandigarh, India
Sayed Ali Sheikh Jouf University, Aljouf, Sakaka, Kingdom of Saudi Arabia
Fuqian Shi Rutgers Cancer Institute of New Jersey, USA
Mohammad Soleimani University of Illinois at Chicago, Chicago, IL, USA
Eser Yildirim Sözmen Izmir Tinaztepe University, Turkey
Victor Strassmann Cleveland Clinic, Ohio, USA
BinBin Sui Beijing Tiantan Hospital, China
Rajesh Tampi Yale School of Medicine, New Haven, CT, USA & Creighton University School of Medicine, Omaha, NE, USA
Joho Tokumine Kyorin University School of Medicine, Japan
Tiago Torres University of Porto, Porto, Portugal
Wen-Jun Tu Capital Medical University - CUCAS, Beijing, China
Francesco Vasuri University Hospital of Bologna IRCCS, Italy
Chien-Chih Wang Taichung Veterans General Hospital, Taiwan
Ying Wang Wildtype Foods RD&I Department, San Francisco, USA
Stanley Wong Hong Kong University, Hong Kong
Mehmet Yalniz Firat University, Turkey
Jae Jun Yang Dongguk University Ilsan Hospital, Goyang, Korea
Senbang Yao The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Mehmet Ali Yesiltas Cemil Tascioglu City Hospital, Istanbul, Turkey
Jinzhou Zhu Soochow University, Suzhou, China
  • Clarivate Analytics: BIOSIS Previews
  • Clarivate Analytics: Current Contents - Life Sciences
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • Directory of Open Access Journals (DOAJ)
  • Elsevier: EMBASE
  • Google Scholar
  • Index Medicus
  • ProQuest
  • PubMed Central (PMC)
  • PubMed: MEDLINE
  • SCOPUS
  • Manuscript submission guidelines can be accessed on Sage Journals.

    Institutional Backfile Purchase, E-access (Content through 1998)